PLK1 and anemia: In contrast, preclinical studies on genetically-engineered mice showed that specific Plk1 mRNA knockdown by short hairpin RNA did not result in typical hematological side effects, such as anemia or neutropenia, and did not affect spermatogenesis or cellular proliferation27.